N/A
N=31,303
The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale
Lung Cancer · Lung Neoplasms/Diagnosis
Bottom Line
View on ClinicalTrials.gov: NCT06338592 ↗Enrolled (actual)
31,303
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Study 1 Primary Outcome: Count of Patients Newly Identified as Eligible for Lung Cancer Screening — 308; 635 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- MyLungHealth (Behavioral); DecisionPrecision+ (Behavioral)
- Age
- Adult, Older Adult · 50+ yrs
- Sex
- All
- Sponsor
- University of Utah
- Primary completion
- Mar 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Study 1 Primary Outcome: Count of Patients Newly Identified as Eligible for Lung Cancer Screening |
308; 635 | — |
| PRIMARY Study 2 Primary Outcome: Count of Participants for Whom LDCT Was Ordered. |
434; 474 | — |
| SECONDARY Study 1 Secondary Outcome: Count of Participants for Whom LDCT Eligibility Status Became Known. |
925; 3,570 | — |
| SECONDARY Study 1 Secondary Outcome: Count of Participants for Whom LDCT Was Ordered. |
350; 430 | — |
| SECONDARY Study 1 Secondary Outcome: Count of Participants for Whom LDCT Was Completed. |
226; 275 | — |
| SECONDARY Study 2 Secondary Outcome: Count of Participants for Whom LDCT Was Completed. |
290; 293 | — |
Summary
Early lung cancer screening (LCS) through low-dose computed tomography (LDCT) is crucial but underused due to various barriers, including incomplete or inaccurate patient smoking data in the electronic health record and limited time for shared decision-making. The objective of this trial is to investigate a patient-centered intervention, MyLungHealth, delivered through the patient portal. The intervention is designed to improve LCS rates through increased identification of eligible patients and informed decision making.
Eligibility Criteria
Inclusion criteria for both study 1 and study 2:
- aged 50-79
- a history of smoking (e.g., current or former tobacco use)
- seen in a study primary care clinic in the 12 months preceding the start of the trial
Exclusion criteria for both study 1 and study 2:
- >0 but < 10 pack-year smoking history or quit more than 15 years ago
- No use of the patient portal at least once in the year preceding the start of the study
- A lung cancer diagnosis at the start of the study
- LDCT completed in the past 3 years
- Another chest CT completed in the past year
- Structured EHR data indicating LCS SDM was provided in the past 3 years
- Exposed to the intervention during the pilot phase
- No visit at a study clinic during the trial period when the intervention was available
Inclusion criteria for study 1:
- a 10-19 pack-year smoking history, an unknown pack-year history, unknown quit date for patients who quit smoking, or a 0 pack-year smoking history
Inclusion criteria for study 2:
- at least a 20 pack-year smoking history and are a current smoker or have quit within the last 15 years
Data sourced from ClinicalTrials.gov (NCT06338592). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.